Citizens Jmp Downgrades Sutro Biopharma (NASDAQ:STRO) to Market Perform
Sutro Biopharma (NASDAQ:STRO – Get Free Report) was downgraded by equities research analysts at Citizens Jmp from an “outperform” rating to a “market perform” rating in a research report issued on Friday, Marketbeat reports. A number of other research analysts also recently commented on the stock. Wells Fargo & Company dropped their target price on […]
Sutro Biopharma (NASDAQ:STRO – Get Free Report) was downgraded by equities research analysts at Citizens Jmp from an “outperform” rating to a “market perform” rating in a research report issued on Friday, Marketbeat reports. A number of other research analysts also recently commented on the stock. Wells Fargo & Company dropped their target price on […]
